HOW I TREAT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA
The greatest improvements in the management of Acute Lymphoblastic Leukemia (ALL) have been witnessed in Ph+ALL patients. The advancements have stemmed from an always more precise genetic characterization at presentation, the use of tailored treatment, the precise monitoring of minima/Measurable Res...
Saved in:
Main Author: | Robin Foà |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-07-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925001373 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanism of action of decitabine in treating acute lymphoblastic leukemia
by: Xiaohui Gao, et al.
Published: (2025-07-01) -
Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01) -
Ophthalmological Manifestations in Acute Lymphoblastic Leukemia
by: Mateo, Javier, et al.
Published: (2011) -
Blinatumomab in pediatric B-acute lymphoblastic leukemia
by: Yifang Cheng, et al.
Published: (2025-07-01) -
Acute Lymphoblastic Leukemia in Adolescents and Young Adults
by: Ribera, Josep-Maria
Published: (2011)